Effectiveness of Myofascial Release and Muscle Energy Technique Compared with Transcutaneous Electrical Nerve Stimulation on Pain, Range of Motion, Functional Status, and Quality of Life in Adults with Chronic Non-Specific Neck Pain: A Randomized Controlled Trial

EFFECTIVENESS OF MYOFASCIAL RELEASE, MUSCLE ENERGY TECHNIQUE, AND TENS ON PAIN, RANGE OF MOTION, FUNCTIONAL STATUS, AND QUALITY OF LIFE IN ADULTS WITH CHRONIC NON-SPECIFIC NECK PAIN: A RANDOMIZED CONTROLLED TRIAL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

SLCTR

Registry ID

SLCTR/2026/001

Enrollment

Unknown

Registered

2026-01-09

Start date

2026-01-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Neck Pain

Interventions

The study will be conducted in the outpatient physiotherapy department of Nawaloka Hospital, Negombo, Sri Lanka. Eligible participants will be randomly allocated into three groups using a computer-gen

Eligibility

Inclusion criteria

Inclusion criteria: • Adults aged 20–40 years * Having chronic non-specific neck pain lasting more than 12 weeks • Pain intensity of VAS ?4 • Both male and female participants Exclusion Criteria • Presence of specific neck pain due to underlying pathology such as cervical disc prolapse, tumor, whiplash injury, cervical fractures, or osteoporosis • Presence of neurological signs consistent with cervical nerve root compression

Exclusion criteria

Exclusion criteria: • Presence of specific neck pain due to underlying pathology such as Cervical disc prolapse, Tumor, Whiplash injury, Cervical fractures, Osteoporosis, presence of neurological signs. • Have pain intensity less than 4 on the VAS scale.

Design outcomes

Primary

Measure	Time frame
1. Pain - Visual analogue scale (VAS) will be used to assess pain severity [These measurements will be taken on the first day before commencing the intervention and after completion of 8 treatment sessions (2 sessions per week), the post measurements will be taken.] 2. Range of motion - Universal goniometer will to used to assess the range of motion. [ ] 3. Quality of life - The short-form 36 (SF-36) questionnaire will be used to assess the quality of life of the participants. [ ] 4. Functional status/disability - The neck disability index (NDI) questionnaire will be used to assess the functional status of the participants [ ] 2. Range of motion - Universal goniometer will to used to assess the range of motion. [ ] 3. Quality of life - The short-form 36 (SF-36) questionnaire will be used to assess the quality of life of the participants. [ ] 4. Functional status/disability - The neck disability index (NDI) questionnaire will be used to assess the functional status of the participants [ ] 2. Range of motion - Universal goniometer will to used to assess the range of motion. [ ] 3. Quality of life - The short-form 36 (SF-36) questionnaire will be used to assess the quality of life of the participants. [ ] 4. Functional status/disability - The neck disability index (NDI) questionnaire will be used to assess the functional status of the participants [ ] 2. Range of motion - Universal goniometer will be used to assess the range of motion. [These measurements will be taken on the first day before commencing the intervention and after completion of 8 treatment sessions (2 sessions per week), the post measurements will be taken.] 3. Quality of life - The short-form 36 (SF-36) questionnaire will be used to assess the quality of life of the participants. [These measurements will be taken on the first day before commencing the intervention and after completion of 8 treatment sessions (2 sessions per week), the post measurements will be taken.] 4. Functional status/disability	—

Measure

Time frame

1. Pain - Visual analogue scale (VAS) will be used to assess pain severity [These measurements will be taken on the first day before commencing the intervention and after completion of 8 treatment sessions (2 sessions per week), the post measurements will be taken.] 2. Range of motion - Universal goniometer will to used to assess the range of motion. [ ] 3. Quality of life - The short-form 36 (SF-36) questionnaire will be used to assess the quality of life of the participants. [ ] 4. Functional status/disability - The neck disability index (NDI) questionnaire will be used to assess the functional status of the participants [ ] 2. Range of motion - Universal goniometer will to used to assess the range of motion. [ ] 3. Quality of life - The short-form 36 (SF-36) questionnaire will be used to assess the quality of life of the participants. [ ] 4. Functional status/disability - The neck disability index (NDI) questionnaire will be used to assess the functional status of the participants [ ] 2. Range of motion - Universal goniometer will to used to assess the range of motion. [ ] 3. Quality of life - The short-form 36 (SF-36) questionnaire will be used to assess the quality of life of the participants. [ ] 4. Functional status/disability - The neck disability index (NDI) questionnaire will be used to assess the functional status of the participants [ ] 2. Range of motion - Universal goniometer will be used to assess the range of motion. [These measurements will be taken on the first day before commencing the intervention and after completion of 8 treatment sessions (2 sessions per week), the post measurements will be taken.] 3. Quality of life - The short-form 36 (SF-36) questionnaire will be used to assess the quality of life of the participants. [These measurements will be taken on the first day before commencing the intervention and after completion of 8 treatment sessions (2 sessions per week), the post measurements will be taken.] 4. Functional status/disability

—

Secondary

Measure	Time frame
None [None]	—

Contacts

Public ContactS.M.Joseph

Post graduate student (MSc in Physiotherapy)

stefyphysio@gmail.com0813999623

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 10, 2026